Novel markers in breast pathology.

Area of Science:

• Oncology
• Pathology
• Biomarker Discovery

Background:

• Breast pathology involves a growing number of biomarkers for disease detection, prognosis, and treatment prediction.
• Biomarkers provide crucial prognostic and predictive information in managing breast cancer.
• Understanding these markers is essential for personalized medicine approaches.

Purpose of the Study:

• To review the current landscape of breast cancer biomarkers.
• To focus on biomarkers utilized in immunohistochemistry, liquid biopsies, and next-generation sequencing.
• To provide an overview of their prognostic and predictive value.

Main Methods:

• Literature review of scientific articles and studies.
• Focus on methodologies including immunohistochemistry, liquid biopsies, and next-generation sequencing.
• Analysis of biomarker applications in breast pathology.

Main Results:

• Biomarkers are integral to modern breast pathology, offering prognostic and predictive insights.
• Immunohistochemistry remains a cornerstone for biomarker assessment.
• Liquid biopsies and next-generation sequencing are emerging as powerful tools for biomarker analysis.

Conclusions:

• Biomarkers are critical for personalized treatment strategies in breast cancer.
• Advancements in techniques like next-generation sequencing are expanding biomarker utility.
• Continued research in biomarker development is vital for improving patient outcomes.